BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1653908)

  • 1. Spindle-cell glioblastoma or gliosarcoma?
    Jones H; Steart PV; Weller RO
    Neuropathol Appl Neurobiol; 1991 Jun; 17(3):177-87. PubMed ID: 1653908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliosarcoma: a histologic and immunohistochemical reaffirmation.
    Meis JM; Ho KL; Nelson JS
    Mod Pathol; 1990 Jan; 3(1):19-24. PubMed ID: 2155418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature.
    Din NU; Ishtiaq H; Rahim S; Abdul-Ghafar J; Ahmad Z
    BMC Pediatr; 2021 Feb; 21(1):101. PubMed ID: 33637068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GFAP, F VIII/RAg, laminin, and fibronectin in gliosarcomas: an immunohistochemical study.
    Schiffer D; Giordana MT; Mauro A; Migheli A
    Acta Neuropathol; 1984; 63(2):108-16. PubMed ID: 6428154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
    Oh JE; Ohta T; Nonoguchi N; Satomi K; Capper D; Pierscianek D; Sure U; Vital A; Paulus W; Mittelbronn M; Antonelli M; Kleihues P; Giangaspero F; Ohgaki H
    Brain Pathol; 2016 Jul; 26(4):517-22. PubMed ID: 26443480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma multiforme with epithelial appearance: a case report.
    Kato K; Watanabe M
    Brain Tumor Pathol; 1999; 16(1):45-8. PubMed ID: 10532423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma.
    McComb RD; Jones TR; Pizzo SV; Bigner DD
    J Neuropathol Exp Neurol; 1982 Sep; 41(5):479-89. PubMed ID: 6286891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative assessment of GFAP-positive and GFAP-negative glioma cells by nucleolar organizer region staining.
    Hara A; Sakai N; Yamada H; Niikawa S; Ohno T; Tanaka T; Mori H
    Surg Neurol; 1991 Sep; 36(3):190-4. PubMed ID: 1652162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.
    Joseph NM; Phillips J; Dahiya S; M Felicella M; Tihan T; Brat DJ; Perry A
    Mod Pathol; 2013 Mar; 26(3):315-26. PubMed ID: 23041832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
    Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
    J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of primary and postirradiation cerebral gliosarcoma.
    Perry JR; Ang LC; Bilbao JM; Muller PJ
    Cancer; 1995 Jun; 75(12):2910-8. PubMed ID: 7773942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectroscopic Characterization of Gliosarcomas-Do They Differ From Glioblastomas and Metastases?
    Raab P; Pilatus U; Hattingen E; Franz K; Hermann E; Zanella FE; Lanfermann H
    J Comput Assist Tomogr; 2016; 40(5):815-9. PubMed ID: 27560009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of glial fibrillary acidic protein (GFAP) by neoplastic cells: adaptation to the microenvironment.
    Herpers MJ; Budka H; McCormick D
    Acta Neuropathol; 1984; 64(4):333-8. PubMed ID: 6391069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smooth muscle can comprise the sarcomatous component of gliosarcomas.
    Haddad SF; Moore SA; Schelper RL; Goeken JA
    J Neuropathol Exp Neurol; 1992 Sep; 51(5):493-8. PubMed ID: 1381414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological appearance, growth kinetics and glial fibrillary acidic protein (GFAP) expression in primary in vitro explant culture of astrocytic neoplasms.
    Kharbanda K; Sarkar C; Dinda AK; Karak AK; Mathur M; Roy S
    Acta Oncol; 1993; 32(3):301-6. PubMed ID: 8391834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inoculation of C6 cell suspension into the brain of adult rats: immunohistochemical study.
    Mokrý J; Nĕmecek S; Adler J; Dĕdic K
    Funct Dev Morphol; 1993; 3(3):175-80. PubMed ID: 8167397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of glial fibrillary acidic protein in avian sarcoma virus-induced gliomas in dogs.
    Britt RH; Lyons BE; Eng LF; Bigner SH; Bigner DD
    J Neurooncol; 1985; 3(1):53-9. PubMed ID: 2987428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the STOML3, FREM2, and LHFP genes is associated with mesenchymal differentiation in gliosarcoma.
    Nagaishi M; Kim YH; Mittelbronn M; Giangaspero F; Paulus W; Brokinkel B; Vital A; Tanaka Y; Nakazato Y; Legras-Lachuer C; Lachuer J; Ohgaki H
    Am J Pathol; 2012 May; 180(5):1816-23. PubMed ID: 22538188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
    Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
    Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.